Variants of the CNTNAP2 5′ promoter as risk factors for autism spectrum disorders: a genetic and functional approach.

MLA

Chiocchetti, A. G., et al. “Variants of the CNTNAP2 5′ Promoter as Risk Factors for Autism Spectrum Disorders: A Genetic and Functional Approach.” Molecular Psychiatry, vol. 20, no. 7, July 2015, pp. 839–49. EBSCOhost, https://doi.org/10.1038/mp.2014.103.

APA

Chiocchetti, A. G., Kopp, M., Waltes, R., Haslinger, D., Duketis, E., Jarczok, T. A., Poustka, F., Voran, A., Graab, U., Meyer, J., Klauck, S. M., Fulda, S., & Freitag, C. M. (2015). Variants of the CNTNAP2 5′ promoter as risk factors for autism spectrum disorders: a genetic and functional approach. Molecular Psychiatry, 20(7), 839–849. https://doi.org/10.1038/mp.2014.103

Chicago

Chiocchetti, A G, M Kopp, R Waltes, D Haslinger, E Duketis, T A Jarczok, F Poustka, et al. 2015. “Variants of the CNTNAP2 5′ Promoter as Risk Factors for Autism Spectrum Disorders: A Genetic and Functional Approach.” Molecular Psychiatry 20 (7): 839–49. doi:10.1038/mp.2014.103.